Schrödinger Unveils Bunsen, an AI Co-Scientist for Enhanced Molecular Discovery

Schrödinger, Inc. (Nasdaq: SDGR) has launched an early access version of Bunsen, its innovative AI co-scientist aimed at assisting researchers in molecular discovery. This new tool helps in understanding scientific objectives, developing computational strategies, and interpreting results through a combination of AI and physics-based simulation. Bunsen enables researchers to expand their exploration of scientific possibilities, prioritize opportunities confidently, and expedite discovery decisions.

As computer-aided drug discovery capabilities grow, so does the complexity of designing and interpreting studies. Bunsen was specifically crafted to tackle these challenges. Unlike general AI systems, Bunsen is tailored to execute Schrödinger's validated computational methods, leveraging decades of expertise in molecular discovery. With Bunsen, researchers can evaluate more hypotheses and navigate chemical spaces effectively, allowing for higher-confidence decisions prior to experimental testing. This capability enables computational chemists to manage concurrent research sessions and enhance productivity.

“In an era where computation is fundamentally changing molecular discovery, Bunsen expands what research teams can accomplish,” stated Ramy Farid, Ph.D., president and CEO of Schrödinger. “Bunsen removes friction from the discovery cycle, enabling greater throughput and expanding the user base for our computational platform. As our customers accelerate their discovery timelines, our throughput-based licensing model is ideally suited to capture the value of this expanding utilization.”

Operating Bunsen necessitates a computing ecosystem that supports large-scale molecular discovery. The collaboration with NVIDIA and Google Cloud brings a co-engineered full stack AI platform to early customers, facilitating the scalability of research organizations' use of the platform across various discovery programs. This partnership also integrates Google Cloud's elastic computing infrastructure with Schrödinger's platform, enhancing it with the NVIDIA BioNeMo™ Agent Toolkit and NVIDIA RTX PRO 6000 Blackwell Server Edition GPUs.

“The future of AI in scientific applications will be defined by agentic AI capable of planning and executing sophisticated, accurate computational workflows,” remarked Anthony Costa, director of Digital Biology at NVIDIA. “The ability to integrate Schrödinger's platform with the NVIDIA BioNeMo Agent Toolkit and NVIDIA accelerated computing technologies demonstrates how agentic AI can help researchers apply advanced computational methods more effectively across molecular discovery.”

Shweta Maniar, global director of Life Sciences Strategy & Solutions at Google Cloud, added, “The most ambitious molecular discovery programs require the ability to rapidly scale scientific computing. We're excited to expand our collaboration with Schrödinger through this customer program. By providing access to the NVIDIA Blackwell platform on Google Cloud to early Bunsen customers, we're helping research organizations realize the potential of leveraging physics combined with agentic AI to expand the scale and use of computation in discovery programs - and accelerate scientific progress.”

Bunsen supports scientists throughout the discovery workflow by helping them:

- Understand scientific objectives and project context.
- Develop computational strategies tailored to scientific questions.
- Execute complex computational workflows across the Schrödinger platform.
- Transform computational results into actionable insights.

The name Bunsen honors pioneering chemist Robert Bunsen, reflecting Schrödinger's dedication to advancing molecular discovery. The early access version of Bunsen is currently available to select customers, with a full commercial release anticipated by the end of 2026.

About Schrödinger: Schrödinger is at the forefront of molecular discovery, utilizing its computational platform to create novel, optimized molecules for drug development and materials design. With over 30 years of R&D investment, Schrödinger's software is utilized by a variety of organizations globally. For more information, visit www.schrodinger.com.

Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking statements regarding the potential advantages of Schrödinger’s computational platform and the early access version of Bunsen. Actual results may differ due to various risks and uncertainties.

Contacts:
Jaren Madden (Investors and Media)
Schrödinger, Inc.
jaren.madden@schrodinger.com
617-286-6264

Matthew Luchini (Investors)
Schrödinger, Inc.
matthew.luchini@schrodinger.com
917-719-0636

Theresa Masnik (Media)
SHIFT Communications
schrodingerpr@shiftcomm.com
508-395-7416